FDA adds another weight loss drug to the US market

摘要

A weight loss drag that combines two other medicines has been approved by the US Food and Drug Administration (FDA). Contrave comprises two drugs already approved for other indications; naltrexone, which is used against alcohol and opioid dependence, and bupropion, an antidepressant